Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
US8822477B2 · kind B2 · utility
1Cited by
3References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 1, 2004 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Mar 25, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of osmolytes, in particular ectoine and hydroxyectoine, as well as their pharmacologically compatible salts and/or derivatives having equivalent effects, for producing dermatological preparations such as tinctures, lotions, O/W emulsions, W/O emulsions, creams, ointments, hydrogels or sprays for the topical prophylaxis, care and/or treatment of neurodermatitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.